Compare Sana Biotechnology Inc (SANA) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Wipro Limited — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Wipro Limited trades at $1.87 (market cap $18.49B). The key difference: Wipro Limited is far larger — about 21.2× Sana Biotechnology Inc's market cap, and Wipro Limited pays a 4.68% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | WIT | |
|---|---|---|
Market Cap | $873.84M | $18.49B |
Sector | Health | Technology |
52-Week High | $5.92 | $3.06 |
52-Week Low | $2.68 | $1.82 |
Enterprise Value | $848.03M | $16.42B |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
